Yahoo Web Search

Search results

    • Axios Vitals

      Axios· 2 days ago

      Why it matters: While regulators have laid out how they think clinical trials can assess hallucinogenic substances like ecstasy and magic mushrooms as behavioral health treatments ...

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 14 hours ago

      Lykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire SAN JOSE, Calif., June 4, 2024 SAN JOSE, Calif., June 4, 2024 /PRNewswire/ -- Lykos Therapeutics ("Lykos"), a company